AbbVie News

San Francisco Reaches $58M Opioid Settlement with Teva, Allergan

Teva Pharmaceutical Industries and AbbVie’s Allergan unit on Tuesday reached a $58 million settlement with the city of San Francisco just before completion of a trial over claims that they fueled an opioid epidemic in the city. Under the deal …

Walgreens, Teva Face San Francisco Trial Over Opioid Epidemic

San Francisco will square off on Monday against Walgreens Boots Alliance and three other companies accused of fueling an opioid crisis in the city, the first trial to target manufacturers, distributors and pharmacies over the addictive pain medicines. San Francisco …

Rhode Island Reaches $107M Opioid Settlements With Teva and Allergan

Rhode Island’s attorney general on Monday announced settlements he valued at $107 million against the drugmakers Teva Pharmaceutical Industries and AbbVie’s Allergan unit to resolve claims over their roles in fueling an opioid epidemic in the state. Attorney General Peter …

AbbVie Unit Settles New York Opioid Case For $200M as Trial Winds Down

Drugmaker AbbVie Inc agreed to pay $200 million to settle claims by New York that it helped fuel an epidemic of opioid addiction in the state, on the day jurors were expected to hear closing arguments at the end of …

Judge Tosses $140M Verdict Against AbbVie Over Testosterone Drug

A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc. in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack. U.S. …